Cyprus Mail
World

Denmark to reconsider exclusion of J&J and AstraZeneca shots

file photo: vials labelled "covid 19 coronavirus vaccine" and sryinge are seen in front of displayed j&j logo in this illustration

Denmark’s government on Monday asked the country’s health authorities to reconsider a decision to exclude Johnson & Johnson’s and AstraZeneca’s COVID-19 shots from its vaccination programme.

The move was prompted by a two-week delay in the Danish vaccination programme to September due to delivery of fewer Moderna and CureVac vaccines than expected, Health Minister Magnus Heunicke said.

Denmark excluded the J&J and AstraZeneca vaccines over a potential link to a rare but serious form of blood clot.

“We are now further into the epidemic, and the vaccines from Johnson & Johnson and AstraZeneca have now been in use in Europe for some time, Heunicke said.

“There is a larger data base worldwide to assess the effect and side effects of the vaccines,” he said.

The health authority found in early May that the benefits of using the COVID-19 vaccines did not outweigh the risk of causing the possible adverse effect in those who receive the vaccine.

Excluding the J&J vaccine, which accounts for around a third of Denmark’s total contracted supplies of COVID-19 shots, delayed the country’s vaccination calendar by up to four weeks, the health authority said.

Denmark had vaccinated 21% of its population as of Monday.

Related Posts

Cuba to send hundreds of doctors to Italy’s Calabria region

Reuters News Service

Latest U.S. aid package to Ukraine includes surveillance drones

Reuters News Service

Nigeria’s Buhari worried over large scale crude oil theft

Reuters News Service

Nord Stream 1 pipeline to shut for three days, increasing pressure on Europe

Reuters News Service

Rare toxic algae behind fish deaths in river Oder, say researchers

Reuters News Service

Islamic State militant gets life in US prison over killing of American hostages

Reuters News Service